Publications by authors named "Richard I Walker"

Claim this Profile
C
Conserved antigens for enteric vaccines.
Richard I Walker

Vaccine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Issue on Enterotoxigenic (ETEC) Vaccines: ETEC Infection and Vaccine-Mediated Immunity.
Frederick J Cassels, Ibrahim Khalil, A Louis Bourgeois, Richard I Walker

Microorganisms· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).
Ibrahim Khalil, John D Anderson, Karoun H Bagamian, Shahida Baqar, Birgitte Giersing, Richard I Walker

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study.
Richard I Walker, A Louis Bourgeois

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled Human Infection Models To Accelerate Vaccine Development.
Robert K M Choy, A Louis Bourgeois, Christian F Ockenhouse, Richard I Walker, Rebecca L Sheets

Clin Microbiol Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
Ann-Mari Svennerholm, Firdausi Qadri, Anna Lundgren, Joanna Kaim, Taufiqur Rahman Bhuiyan, Richard I Walker

Vaccine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children.
Protim Sarker, Akhirunnesa Mily, Anjuman Ara, Farjana Haque, Nicole Maier, Richard I Walker

J Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of WRSS1, a live oral vaccine in Bangladeshi adults and children.
Rubhana Raqib, Protim Sarker, K Zaman, Nur Haque Alam, Thomas F Wierzba, Richard I Walker

Hum Vaccin Immunother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
Firdausi Qadri, Marjahan Akhtar, Taufiqur R Bhuiyan, Mohiul I Chowdhury, Tasnuva Ahmed, Richard I Walker

Lancet Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.
Marjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, Joanna Kaim, Tasnuva Ahmed, Richard I Walker

Vaccine· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preface.
Richard I Walker, Mark S Riddle, Allison Clifford

Vaccine· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference.
Richard I Walker, Thomas F Wierzba, Sachin Mani, A Louis Bourgeois

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of vaccine research and development for Shigella.
Sachin Mani, Thomas Wierzba, Richard I Walker

Vaccine· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of vaccine research and development for enterotoxigenic Escherichia coli.
A Louis Bourgeois, Thomas F Wierzba, Richard I Walker

Vaccine· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of vaccine research and development for norovirus.
Mark S Riddle, Richard I Walker

Vaccine· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment.
Mihai Pop, Joseph N Paulson, Subhra Chakraborty, Irina Astrovskaya, Brianna R Lindsay, Alan W Walker, Richard I Walker

BMC Genomics· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.
Richard I Walker

Vaccine· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infants.
Richard I Walker, Allison Clifford

Vaccine· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
Francisco J Martinez-Becerra, Xiaotong Chen, Nicholas E Dickenson, Shyamal P Choudhari, Kelly Harrison, Richard I Walker

Infect Immun· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.
Clayton Harro, Subhra Chakraborty, Andrea Feller, Barbara DeNearing, Alicia Cage, Richard I Walker

Clin Vaccine Immunol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.
David R Tribble, Shahida Baqar, Daniel A Scott, Michael L Oplinger, Fernando Trespalacios, Richard I Walker

Infect Immun· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis.
J S Hill Gaston, Robert D Inman, Edward T Ryan, Malabi M Venkatesan, Eileen M Barry, Richard I Walker

Vaccine· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease.
Richard I Walker, Duncan Steele, Teresa Aguado,

Vaccine· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine potential for inactivated shigellae.
Manuel Osorio, Mechelle D Bray, Richard I Walker

Vaccine· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New vaccines against enteric bacteria for children in less developed countries.
Richard I Walker

Expert Rev Vaccines· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis